Nurix Therapeutics, Inc. (NRIX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$5,186
Total Return
-48.14%
CAGR
-12.31%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.14% |
| Median | -1.73% |
| Best | +86.21% |
| Worst | -50.12% |
| % of Windows Positive | 45.2% |
1-Year (252 Trading Days)
| Average | +12.78% |
| Median | -23.11% |
| Best | +518.12% |
| Worst | -69.55% |
| % of Windows Positive | 35.8% |
3-Year (756 Trading Days)
| Average | +2.20% |
| Median | -9.76% |
| Best | +89.30% |
| Worst | -51.52% |
| % of Windows Positive | 38.7% |
Risk Metrics
| Maximum Drawdown | -88.42% |
| Average Drawdown | -56.20% |
| Drawdown Duration | 1186 Trading Days (Unrecovered) |
| Sortino Ratio | 0.27 |
| Calmar Ratio | -0.14 |
| CVaR (5%) | -9.42% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -18.40% (-38.26% ann.) | $1839.75 | $0.00 | $0.00 | $0.00 |
| 2025 | +0.69% | +$69.01 | $0.00 | $0.00 | $0.00 |
| 2024 | +82.56% | +$8255.81 | $0.00 | $0.00 | $0.00 |
| 2023 | -6.01% | $601.10 | $0.00 | $0.00 | $0.00 |
| 2022 | -62.07% | $6207.25 | $0.00 | $0.00 | $0.00 |
| 2021 | -11.95% | $1195.25 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +72.96% (+249.30% ann.) | +$7296.16 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | July 24, 2020 – November 6, 2020 | +21.99% | +99.65% | +$2198.84 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +26.39% | +24.88% | +$2638.95 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -58.36% | -60.56% | $5836.22 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +80.85% | +37.66% | +$8084.50 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -37.43% | -24.03% | $3742.93 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.